OSCR
Oscar Health, Inc. · Healthcare · Medical - Healthcare Plans
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.63M | $81.23M | n/a | n/a |
| Q2 2026 | 121 | +14 | 136.98M | $3.90B | +21 | −8 |
| Q1 2026 | 111 | -1 | 110.57M | $1.27B | +11 | −13 |
| Q4 2025 | 112 | -3 | 121.38M | $1.74B | +2 | −4 |
| Q3 2025 | 22 | +3 | 74.59M | $1.41B | +5 | −3 |
| Q2 2025 | 17 | -1 | 57.51M | $1.23B | +1 | −2 |
| Q1 2025 | 15 | -1 | 25.41M | $333.18M | +2 | −3 |
| Q4 2024 | 16 | -1 | 29.22M | $392.74M | +2 | −3 |
| Q3 2024 | 16 | +2 | 34.05M | $722.32M | +2 | n/a |
| Q2 2024 | 14 | n/a | 28.60M | $452.40M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 2.59M | +3.8% | $79.87M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 29.03K | +7.9% | $960,761 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 13.35K | +16.7% | $399,032 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 84.20K shares, $965 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 25.00K sh · $806,000
Officer · 958 sh · $30,129
Officer · 10.36K sh · $325,822
Officer · 9.09K sh · $285,943
Director · 31.42K sh · $988,222
Officer · 28.87K sh · $907,930
Director · 150.00K sh · $4.62M
Director · 600.00K sh · $18.20M
Officer · 18.75K sh · $595,125
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
1.7% of class · View original SEC filing ↗